Cost and cost effectiveness of Herpes simplex virus-type 2 (hsv-2) suppressive therapy in HIV-1 and HSV-2 infected women in Johannesburg, South Africa
ADevine;
GMeyer-Rath;
AFoss;
PVickerman;
MEdwards;
MBachmann;
PMayaud;
SDelany-Moretlwe;
(2009)
Cost and cost effectiveness of Herpes simplex virus-type 2 (hsv-2) suppressive therapy in HIV-1 and HSV-2 infected women in Johannesburg, South Africa.
[Conference or Workshop Item]
https://material-uat.leaf.cosector.com/id/eprint/5470
| Item Type | Conference or Workshop Item (UNSPECIFIED) |
|---|
Downloads
Full text not available from this repository.
Explore Further
Read more research from the creator(s):
Find work associated with the faculties and division(s):
- Dept of Clinical Research
- Dept of Global Health and Development
- Dept of Health Services Research and Policy
Find work associated with the research centre(s):
- Centre for Maternal, Reproductive and Child Health (MARCH)
- Social and Mathematical Epidemiology (SaME)
Find work from this publication: